Status:
TERMINATED
Ultrasonic Neuromodulation for Treatment of Cognitive Impairment
Lead Sponsor:
University of Utah
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
This study will evaluate a new form of non-invasive deep brain therapy for individuals with Alzheimer's disease. Low-intensity transcranial focused ultrasound stimulation will first be delivered using...
Eligibility Criteria
Inclusion
- Mild cognitive impairment or mild dementia due to Alzheimer's disase (AD) with confirmed AD biomarkers (Amyloid PET or CSF)
- Age 65-80
- MOCA \> 18
Exclusion
- Evidence of cerebral amyloid angiopathy or stroke within 1 year
- Clinical symptoms or findings suggestive of alternative diagnosis or co-pathology
- Inability to complete MRI
- Suicidal ideation
Key Trial Info
Start Date :
August 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 21 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06135051
Start Date
August 18 2024
End Date
August 21 2024
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84108